« Back
Home /
Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1)

Manufacturer	Selleckchem
Category	Oncology Antibodies By Cell Type Carcinoma Hematology Lymphoma Myelofibrosis Primary Antibodies
Type	Antibody
Specific against	other
Amount	1 mg x 5
Item no.	A2002-5
Targets	CD279
CASRN	946414-94-4
eClass 6.1	32160702
eClass 9.0	32160702
Available
Information	Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 5

available

Delivery expected until 5/16/2024